Space Oncology

Space Oncology is a new frontier in cancer research, investigating how microgravity and cosmic radiation impact cancer progression and treatment. Read here to learn more.

Cancer is emerging as one of the world’s greatest public health challenges, with India expected to record nearly 1.87 million new cancer cases in 2026, placing an enormous burden on healthcare systems, the economy, and society.

In this context, space oncology has gained global attention as a revolutionary field that utilises the unique environment of space, particularly microgravity and space radiation, to study cancer biology, accelerate drug discovery, and develop advanced cancer therapies that are difficult to achieve under Earth’s gravity.

What is Space Oncology?

Space oncology is an interdisciplinary field combining space science, oncology, biotechnology, molecular biology, and biomedical engineering to understand how the space environment influences cancer development, progression, and treatment.

• Unlike conventional laboratory research, experiments conducted aboard the International Space Station (ISS) or other microgravity platforms expose cancer cells to conditions that fundamentally alter their biological behaviour.
• These changes provide scientists with new insights into tumour formation, metastasis, drug resistance, and therapeutic responses.
• Space serves as a natural laboratory, allowing researchers to observe biological processes that are often masked by Earth’s gravitational forces.

Why is Space Important for Cancer Research?

Unique Microgravity Environment

Microgravity significantly alters cellular behaviour by removing the constant gravitational forces experienced on Earth. This affects:

• Cell growth
• Cell communication
• Gene expression
• Protein synthesis
• Tissue organization
• Drug absorption

As a result, scientists can study cancer cells from an entirely different biological perspective.

Cosmic Radiation

Space also exposes cells to:

• High-energy cosmic rays
• Solar radiation
• Heavy ion particles

These help researchers understand:

• DNA damage
• Mutation mechanisms
• Cancer initiation
• Radiation resistance
• Radiation-induced cancers

This knowledge is valuable not only for astronauts but also for improving radiation therapy on Earth.

Space as a Three-Dimensional Laboratory

On Earth, cancer cells generally grow as flat two-dimensional cultures.

In microgravity, they naturally form:

• Three-dimensional tumour spheroids
• Tissue-like structures
• Organ-like cellular assemblies

These closely resemble actual human tumours, making drug testing much more reliable.

Importance of Space Oncology

Rising Cancer Burden

Cancer results from the uncontrolled division of abnormal cells.

According to estimates:

• India may witness 1.87 million new cancer cases in 2026
• Breast, lung, cervical, colorectal and gastrointestinal cancers continue to rise.
• Population ageing and lifestyle changes are major contributors.

Economic Burden

Cancer affects households through:

• High treatment expenditure
• Long-term medication costs
• Loss of productivity
• Caregiver burden
• Catastrophic health expenditure
• Poverty due to prolonged illness

Better therapies developed through space research could substantially reduce treatment costs in the future.

Better Disease Models

Microgravity allows researchers to create realistic tumour models.

These models help scientists understand:

• Cancer initiation
• Tumour growth
• Metastasis
• Immune interactions
• Drug resistance

more accurately than traditional laboratory systems.

Faster Drug Discovery

Space-based experiments improve:

• Drug screening
• Protein crystallization
• Nanomedicine development
• Targeted drug delivery
• Precision medicine

This shortens the time required to identify effective anti-cancer drugs.

How Does Microgravity Affect Cancer Cells?

Microgravity causes profound biological changes inside cancer cells.

Cytoskeletal Reorganization

The cytoskeleton acts as the internal skeleton of a cell.

In microgravity:

• Cell shape changes
• Mechanical strength decreases
• Cell migration is altered
• Tumour invasion may reduce

Altered Cell Adhesion

Cancer cells interact with neighbouring cells and surrounding tissues through adhesion molecules.

Microgravity modifies:

• Focal adhesion proteins
• Integrin signalling
• Extracellular matrix interactions

This helps researchers understand how metastasis begins.

Changes in Gene Expression

Thousands of genes behave differently in microgravity.

Altered expression patterns are shown by genes regulating:

• Cell cycle
• Apoptosis
• DNA repair
• Angiogenesis
• Immune response
• Drug resistance

Tumour Spheroid Formation

One of the most important discoveries is the spontaneous formation of:

• Multicellular tumour spheroids

These spheroids:

• closely resemble human tumours
• develop oxygen gradients
• exhibit realistic drug penetration
• simulate tumour microenvironments

They are superior to conventional laboratory cultures.

Drug Sensitivity

Microgravity alters:

• drug uptake
• membrane permeability
• transporter proteins
• metabolic pathways

As a result, some cancer drugs become more effective, while others reveal resistance mechanisms previously unknown.

Space Oncology and Different Types of Cancer

Breast Cancer

Studies show microgravity can:

• reduce tumour aggressiveness
• alter cell-cycle regulation
• decrease migration
• improve responsiveness to targeted therapies
• facilitate tumour spheroid formation

This may improve treatment strategies for metastatic breast cancer.

Gastrointestinal Cancers

Research indicates:

• altered tumour progression
• modified protein expression
• enhanced drug sensitivity
• reduced resistance gene activity

These findings may lead to better chemotherapy regimens.

Other Cancer Types Being Investigated

Researchers are also studying:

• Lung cancer
• Colorectal cancer
• Ovarian cancer
• Prostate cancer
• Brain tumours
• Leukemia
• Melanoma

Applications of Space Oncology

Drug Discovery

Microgravity accelerates the identification of:

• new drug targets
• novel therapeutic molecules
• anti-metastatic drugs

Protein Crystallization

Space enables the growth of:

• larger
• purer
• highly ordered protein crystals

These improve understanding of cancer proteins and aid rational drug design.

Precision Medicine

Space experiments may help identify:

• biomarkers
• genetic signatures
• personalized treatment strategies

Nanomedicine

Microgravity may reduce the side effects of chemotherapy as it supports:

• nanoparticle formulation
• controlled drug release
• targeted drug delivery systems

Tissue Engineering

Scientists can develop:

• artificial tumour tissues
• organoids
• cancer-on-chip models

Global Progress in Space Oncology

Several organisations are actively conducting cancer experiments in space.

These include:

• NASA
• European Space Agency (ESA)
• Japan Aerospace Exploration Agency (JAXA)
• International Space Station (ISS)
• Commercial space laboratories

Numerous pharmaceutical companies are also exploring space-based drug development.

India’s Opportunities in Space Oncology

India possesses unique strengths that position it well to become a major player in this emerging field.

ISRO’s Growing Capabilities

• India’s successful missions and expanding space infrastructure provide an excellent platform for biomedical research.
• Future human spaceflight missions under Gaganyaan could facilitate indigenous microgravity experiments.

Growing Biotechnology Sector

India has:

• one of the world’s largest pharmaceutical industries
• strong biotechnology capabilities
• advanced medical research institutions

These can be integrated with space research.

Public-Private Partnerships

Collaborations will help accelerate innovation:

• ISRO
• Department of Biotechnology
• ICMR
• AIIMS
• Pharmaceutical companies
• Private space startups

Affordable Cancer Solutions

India can leverage its expertise in affordable healthcare to develop:

• low-cost diagnostics
• targeted therapies
• precision drug delivery systems
• indigenous cancer medicines

Global Leadership

With:

• lower launch costs
• a rapidly growing commercial space ecosystem
• increasing international collaborations

India has the potential to become a global hub for space biotechnology and space oncology research.

Challenges in Space Oncology

• Extremely high cost of conducting space experiments.
• Limited access to spaceflight opportunities.
• Small sample sizes and short experiment durations.
• Complex logistics for transporting biological samples.
• Need for multidisciplinary collaboration between oncologists, space scientists, engineers, and biologists.
• Ethical and regulatory challenges for translating findings into clinical practice.

Way Forward

• Integrate space oncology into India’s national cancer research strategy.
• Establish dedicated space-biomedicine laboratories under ISRO and research institutions.
• Promote public-private partnerships in space-based pharmaceutical research.
• Encourage international collaboration with NASA, ESA, JAXA, and other agencies.
• Expand funding for cancer research using microgravity platforms.
• Develop indigenous technologies for space-enabled drug discovery, tissue engineering, and precision medicine.
• Translate laboratory findings into affordable therapies benefiting cancer patients on Earth.

Conclusion

Space oncology represents a transformative frontier where space science meets medicine. By exploiting the unique conditions of microgravity and cosmic radiation, researchers can gain unprecedented insights into tumour biology, metastasis, and drug response that are difficult to achieve on Earth.

For India, with its expanding space capabilities and robust pharmaceutical ecosystem, space oncology offers a strategic opportunity to advance biomedical innovation, develop affordable cancer therapies, and emerge as a global leader in space-based healthcare research.

As space missions become more accessible, the discoveries made beyond Earth may ultimately revolutionise cancer diagnosis and treatment for millions of patients worldwide.